Chinese biotech firm Argo Biopharmaceutical has finalized four banks for a planned Hong Kong listing, Bloomberg reported Thursday.
The company has picked Bank of America, China International Capital, Jefferies Financial Group, and JPMorgan Chase for the initial public offering.
The terms of the listing are still being finalized, but the compny has filed confidentially for the IPO, the report said.
(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)